1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow rubitecan: new trials by email Literature Review of rubitecan trials Research Report on rubitecan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer Rubitecan - Pancreatic Cancer | Phase 2 / Phase 3 | Terminated | Astex Pharmaceuticals, Inc. | 39 | 2005-02-01 | 2024-08-02 |
Adenocarcinoma (1) · Pancreatic Neoplasms (1)
Astex Pharmaceuticals, Inc. (1)
United States (1)